Accelrys Acquires Aegis Analytical Corp. for $30 million in Cash
SAN DIEGO, Oct. 23, 2012 /PRNewswire/ -- Accelrys, Inc.
(NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software, today announced that it has acquired
Aegis Analytical Corp. (Aegis) for $30
million in cash, expanding Accelrys' portfolio with
enterprise manufacturing process intelligence capabilities that
provide organizations with unmatched insights into their product
lifecycle processes. The addition of Aegis' industry-leading
software to the recently announced Accelrys Process Management and
Compliance Suite fills an unmet need in the marketplace as
organizations struggle to optimize their lab-to-commercialization
processes, manage quality control with external collaborators and
reduce compliance risk.
(Logo:
http://photos.prnewswire.com/prnh/20120416/MM88629LOGO)
Accelrys retained key members of the Aegis management team,
along with Aegis employees, as part of the transaction.
"The industries we serve are undergoing significant changes,
requiring them to move from a status quo approach to one that
breaks down the barriers to operational excellence, innovation
productivity and global competitiveness," said Accelrys President
and Chief Executive Officer Max
Carnecchia. "This acquisition expands our footprint in
downstream operations with valuable new solutions for electronic
process intelligence, and reinforces our position as a leader in
scientific innovation lifecycle management software."
Science-driven industries, especially those that operate in
regulated environments, find it difficult to accelerate product
development and manage complex manufacturing in real-time because
they rely on an outmoded combination of paper notebooks,
proprietary tools and disconnected point solutions. As a result,
they also struggle to meet Quality by Design (QbD) and
International Conference on Harmonization (ICH) objectives, to
improve seamless technology transfer from research to
manufacturing, and to deliver robust and high-quality regulatory
filings. Solving these problems requires a holistic approach that
enables businesses to predict, prevent and solve problems
throughout the product development, quality and manufacturing
process.
Aegis' Discoverant software aggregates, contextualizes and
analyzes manufacturing, quality and product development data,
enabling quality and manufacturing organizations to gain predictive
control of their processes. By adding these capabilities to
Accelrys' Process Management and Compliance Suite, which includes
the electronic laboratory notebook, lab execution system,
electronic batch records and enterprise scientific informatics
platform, Accelrys offers a unified solution that helps
organizations in validated environments achieve better outcomes and
breakthrough results. Importantly, with the increased visibility of
process data and improved process understanding throughout the
product development lifecycles, the suite also addresses two
growing trends in the industry – externalization and increased
investments in biologics development.
"Externalization is changing the way pharmaceuticals,
biotechnology, chemical and other regulated industries do business.
These companies now have external partners and collaborators across
the value chain, from research to manufacturing, that span the
globe," said Ken Rapp, Accelrys'
managing director of analytical, development, quality and
manufacturing solutions. "Without visibility into their
far-reaching global operations, companies risk compromising the
quality of their products and noncompliance with regulatory
requirements, slowing operations and significantly increasing the
cost of bringing products to market."
Aegis, based in Lafayette,
Colo., has more than 15 years of experience in process
development and manufacturing and was recognized in Gartner's "Cool
Vendors in Manufacturing Operations, 2012."
"This acquisition brings significant value to Aegis' customers,
offering them a comprehensive software portfolio for managing the
scientific innovation lifecycle and providing them access to the
global resources of an industry leader," said Aegis President and
Chief Executive Officer Robert Di
Scipio. "The Aegis team looks forward to joining Accelrys
and to working together to continue producing innovative solutions
for science-driven organizations."
About Accelrys, Inc.
Accelrys (NASDAQ:ACCL), a leading
provider of scientific innovation lifecycle management software,
supports industries and organizations that rely on scientific
innovation to differentiate themselves. The industry-leading
Accelrys Enterprise Platform provides a broad, flexible scientific
solution optimized to integrate the diversity of science,
experimental processes and information requirements across the
research, development, process scale-up and early manufacturing
phases of product development. By incorporating capabilities in
applications for modeling and simulation, enterprise lab
management, workflow and automation, and data management and
informatics, Accelrys enables scientific innovators to access,
organize, analyze and share data in unprecedented ways, ultimately
enhancing innovation, improving productivity and compliance,
reducing costs and speeding time from lab to market.
Accelrys solutions are used by more than 1,300 companies in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego,
Calif., Accelrys employs more than 200 full-time PhD
scientists. For more information about Accelrys, visit
www.accelrys.com.
SOURCE Accelrys, Inc.